Doctors hopeful about Hepatitis B functional cure

A new drug called Hibsago has been approved in Canada, offering a potential 'functional cure' for chronic Hepatitis B. Patients who previously faced lifelong health risks and liver damage now have a new treatment option to suppress the virus to negligible levels.
Why it matters
This development provides significant medical relief for thousands of patients living with a chronic, potentially life-threatening viral infection.
Copy Link Email X Reddit Pinterest LinkedIn Tumblr New cure arrives for chronic, lifelong hepatitis B infection A new drug, Hibsago, can bring the virus to negligible levels for some patients
Join the conversation A human liver anatomy model. Hepatitis B attacks the liver, but a new drug may help more people with the disease get treatment. Panuwat Dangsungnoen/Getty Images Article content Jeff Lumfsden never had an inkling that something was wrong.
Create an account or sign in to continue with your reading experience.
So it came as a shock when a routine blood donation three years ago led to a diagnosis of chronic hepatitis B.
“(It) made me immediately start to think that this was a death sentence,” Lumfsden said. “I didn’t know anything about the disease.”
But new research is providing new hope for patients.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in